The use of neuromuscular blocking agents to investigate receptor structure requirements for histamine release.
D000731:Androstanes / Q000494:pharmacology; D000818:Animals; D006636:Histamine Release; D008407:Mast Cells / Q000378:metabolism; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology*; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug; D013268:Stimulation, Chemical; D014117:Toxiferine / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology; D003189:p-Methoxy-N-methylphenethylamine / Q000494:pharmacology
D000731:Androstanes; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D010880:Piperidines; D011955:Receptors, Drug; D003189:p-Methoxy-N-methylphenethylamine; D014117:Toxiferine; D014403:Tubocurarine